NEWS
Dr. Ming Zhou, featured speaker in Solute Carrier Proteins symposium at the NY Academy of Sciences
To work properly, the cells in our body use carrier proteins to control the transport of ions, such as potassium,...
World-class oral presentations featured at ARRS 2016 Annual Meeting
Leesburg, VA, April 25, 2016– Oral presentations delivered by some of the world's most renowned researchers and radiologists were among...
Vitamin D insufficiency, low rate of DNA methylation in black teens may increase disease risk
AUGUSTA, Ga. – Low levels of vitamin D in black teens correlates with low activity of a major mechanism for...
Chronic inflammation leads to imbalanced blood system and potentially cancer risk
A study published today in the journal Nature Cell Biology shows that chronic exposure to an inflammatory "emergency" signal, interleukin-1,...
Key mechanism identified in brain tumor growth
A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new...
Top tobacco control experts to FDA: Studies of e-cigs suggest more benefit than harm
WASHINGTON — Seven top international tobacco control experts are prompting regulators at the U.S. Food and Drug Administration (FDA) to...
Stem cells used to successfully regenerate damage in corticospinal injury
Writing in the March 28, 2016 issue of Nature Medicine, researchers at University of California, San Diego School of Medicine...
Handheld surgical ‘pen’ prints human stem cells
In a landmark proof-of-concept experiment, Australian researchers have used a handheld 3D printing pen to ‘draw’ human stem cells in...
UCI study finds safer stem cell-derived therapy for brain radiation recovery
Irvine, Calif., April 7, 2016 — While stem cells have shown promise for treating brain regions damaged by cancer radiation...
Identification of therapeutic targets in multiple myeloma
Multiple myeloma (MM) is a hematological cancer that frequently acquires resistance to chemotherapeutic drugs. Additionally, many patients experience disease relapse,...
Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer
Immunotherapy represents an exciting advance in cancer treatment that harnesses the immune system to seek and destroy cancer cells. The...
VCU Massey researchers uncover process that drives prostate cancer metastasis
Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps...
The cell copying machine: How daughters look like their mothers
Tiny structures in our cells, called centrioles, control both cell division and motility. The number of these structures is highly...
Researchers identify new mechanism to target ‘undruggable’ cancer gene
(NEW YORK, NY, April 18, 2016) — RAS genes are mutated in more than 30 percent of human cancers and...
Young adult survivors of childhood cancer report feeling middle-aged
BOSTON (April 21, 2016) – Do survivors of childhood cancer return to normal health as they grow up? According to...
No risk association observed for anthracycline chemotherapy, cognitive decline
New data analyses found no association between anthracycline chemotherapy and greater risk of cognitive decline in breast cancer survivors, according...
No increased risk of fatal CV events for breast cancer patients on newer hormone therapy
PASADENA, Calif., April 21, 2016 –In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy...
Wellderly study suggests link between cognitive decline genes and healthy aging
LA JOLLA, Calif. – An eight-year-long accrual and analysis of the whole genome sequences of healthy elderly people, or "Wellderly,"...
Study finds explanation for some treatment-resistant breast cancers
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in...
Study reveals a basis for attention deficits
More than 3 million Americans suffer from attention deficit hyperactivity disorder (ADHD), a condition that usually emerges in childhood and...